A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/nzqcuOwAjc A new AI model can accurately predict human response to novel drug compounds https://t.co/KyVUN9ojoO @_atanas_
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2022 – Nov 2023Where it's discussed
-
News26 articles
-
X / Twitter14 posts
-
YouTube3 videos
-
Blogs3 articles
AI synopsis
What people are saying
The groups emphasize the innovative nature of the autoencoder, with phrases like 'new AI model' and 'robust prediction,' reflecting excitement and perceived high impact. Words like 'accurately predict' and mentions of 'personalized clinical drug response' demonstrate interest, while references to 'Nature Machine Intelligence' and remarks on 'methodological advancements' show active engagement and deeper understanding.
Most discussions acknowledge and support the significance and potential of the new autoencoder model for predicting personalized drug responses.
Posts demonstrate high curiosity and enthusiasm, often mentioning innovative aspects of the model and its applications.
The discussions include references to methodological details and implications, indicating active engagement, though some posts are more superficial.
Several posts highlight the transformative impact of the research, such as improving personalized medicine and drug development, showing high perceived significance.
Abstract in brief
- The accuracy of predicting how individual patients respond to new drugs is vital for personalized medicine, but limited patient data makes it challenging to create effective machine learning models.
- Despite existing methods to leverage cell-line data for these predictions, issues like data variability lead to unreliable outcomes.
- The newly developed CODE-AE autoencoder addresses these challenges by extracting relevant biological signals and improving prediction accuracy for patient-specific drug responses, demonstrating promise in screening multiple drugs for a large cancer patient population.
Top posts
Most liked on X and BlueskyA context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/gTCJQkFufy
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening #machinelearning https://t.co/yxCFqQaxyT
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening | Nature Machine Intelligence https://t.co/iM4zbPjXJT
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening with Lei Xie and Kyle Cool https://t.co/BPIriPXdEG
RT A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/qyEz52Yw89 https://t.co/amcQMC1YWr
All mentions
Advancing Personalized Medicine with the CODE-AE Autoencoder Model
In this episode, Dr Xie discusses developing the CODE-AE autoencoder, which enhances prediction accuracy of individual drug responses by extracting relevant biological signals amid data scarcity and variability, aiding…
Deconfounding Autoencoder for Accurate Personalized Drug Response Prediction
This video explains how a new autoencoder model predicts patient-specific drug responses more accurately by addressing data variability and heterogeneity, enhancing personalized cancer treatment.
Deconfounding Autoencoder for Personalized Drug Response Prediction in Cancer Treatments
This video explains a new machine learning model called CODE-AE, which enhances the prediction of individual patient drug responses by addressing data variability and extracting relevant biological signals, supporting…
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening with Lei Xie and Kyle Cool https://t.co/w66l2lzirE
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening with Lei Xie and Kyle Cool https://t.co/BPIriPXdEG
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/gTCJQkFufy
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening #machinelearning https://t.co/yxCFqQaxyT
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
RT @erlesen: A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound…
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/nzqcuOwAjc A new AI model can accurately predict human response to novel drug compounds https://t.co/KyVUN9ojoO @_atanas_
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening | Nature Machine Intelligence https://t.co/iM4zbPjXJT
RT A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening https://t.co/qyEz52Yw89 https://t.co/amcQMC1YWr